Cholangiocarcinoma in association with Thorotrast exposure

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 11, Issue 6, 2004, Pages 430-433

  Zhu, Andrew X ^a,b   Lauwers, Gregory Y ^a,b   Tanabe, Kenneth K ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cholangiocarcinoma; Thorotrast

Indexed keywords

CONTRAST MEDIUM; THORIUM DIOXIDE;

AGED; ARTICLE; BILE DUCT CARCINOMA; CALCIFICATION; CANCER DIAGNOSIS; CANCER THERAPY; CARCINOGENICITY; CASE REPORT; COLLOID; DISEASE ASSOCIATION; DRUG ACCUMULATION; DRUG EXPOSURE; DRUG RETENTION; FEMALE; GENERAL HOSPITAL; HUMAN; HUMAN TISSUE; IONIZING RADIATION; LIVER FIBROSIS; LIVER RESECTION; MALE; MEDIASTINUM LYMPH NODE; MEDICAL LITERATURE; PATHOLOGY; RADIOLOGY; RETICULOENDOTHELIAL SYSTEM; SUSPENSION;

AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; HEPATECTOMY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASMS, RADIATION-INDUCED; THORIUM DIOXIDE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 11244255252     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00534-004-0924-5     Document Type: Article

References (13)

1. Nyberg U, Nilsson B, Travis LB, Holm LE, Hall P (2002) Cancer incidence among Swedish patients exposed to radioactive thorotrast: A 40-year follow-up survey. Radiat Res 157:419-425
2. Sharp GB (2002) The relationship between internally deposited alpha-particle radiation and subsite-specific liver cancer and liver cirrhosis: An analysis of published data. J Radiat Res (Tokyo) 43:371-380
3. dos Santos Silva I, Malveiro F, Jones ME, Swerdlow AJ (2003) Mortality after radiological investigation with radioactive Thorotrast: A follow-up study of up to 50 years in Portugal. Radiat Res 159:521-534
4. Lee FI, Tharakan J, Vasudev KS, Isaacs PE (1996) Malignant hepatic tumours associated with previous exposure to Thorotrast: four cases. Eur J Gastroenterol Hepatol 8:1121-1124
5. Ishikawa Y, Wada I, Fukumoto M (2001) Alpha-particle carcinogenesis in Thorotrast patients: Epidemiology, dosimetry, pathology, and molecular analysis. J Environ Pathol Toxicol Oncol 20:311-315
6. Kato I, Kido C (1987) Increased risk of death in thorotrastexposed patients during the late follow-up period. Jpn J Cancer Res 78:1187-1192
7. Mori T, Kido C, Fukutomi K, Kato Y, Hatakeyama S, Machinami R, Ishikawa Y, Kumatori T, Sasaki F, Hirota Y, Kiyosawa K, Hayashi S, Tanooka H, Sobue T (1999) Summary of entire Japanese thorotrast follow-up study: Updated 1998. Radiat Res 152(6 Suppl):S84-87
8. Launois B, Maddern G, Tay KH (1999) The Glissonian approach of the hilum. Swiss Surg 5:143-146
9. Launois B, Jamieson GG (1992) The posterior intrahepatic approach for hepatectomy or removal of segments of the liver. Surg Gynecol Obstet 174:155-158
10. Przygodzki RM, Finkelstein SD, Keohavong P, Zhu D, Bakker A, Swalsky PA, Soini Y, Ishak KG, Bennett WP (1997) Sporadic and Thortrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2. Lab Invest 76:153-159
11. Kamikawa T, Amenomori M, Itoh T, Momoi H, Hiai H, Machinami R, Ishikawa Y, Mori T, Shimahara Y, Yamaoka Y, Fukumoto M (1999) Analysis of genetic changes in intrahepatic cholangiocarcinoma induced by thorotrast. Radiat Res 152(6 Suppl):S118-124
12. Liu D, Momoi H, Li L, Ishikawa Y, Fukumoto M (2002) Microsatellite instability in thorotrast-induced human intrahepatic cholangiocarcinoma. Int J Cancer 102:366-371
13. Ito Y, Kojiro M, Nakashima T, Mori T (1988) Pathomorphologic characteristics of 102 cases of thorotrast-related hepatocellular carcinoma, cholangiocarcinoma, and hepatic angiosarcoma. Cancer 62:1153-1162